标题
The JUPITER Trial: Myth or Reality?
作者
关键词
-
出版物
Current Atherosclerosis Reports
Volume 13, Issue 5, Pages 413-421
出版商
Springer Nature
发表日期
2011-07-25
DOI
10.1007/s11883-011-0197-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Forecasting the Future of Cardiovascular Disease in the United States
- (2011) Paul A. Heidenreich et al. CIRCULATION
- The Cost-Effectiveness of Rosuvastatin Therapy
- (2011) Mark Hlatky JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Cost-Effectiveness of C-Reactive Protein Testing and Rosuvastatin Treatment for Patients With Normal Cholesterol Levels
- (2011) Niteesh K. Choudhry et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
- (2011) Heart Protection Study Collaborative Group LANCET
- The JUPITER Trial: Responding to the Critics
- (2010) Paul M. Ridker et al. AMERICAN JOURNAL OF CARDIOLOGY
- Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
- (2010) Paul M. Ridker et al. AMERICAN JOURNAL OF CARDIOLOGY
- Statins and All-Cause Mortality in High-Risk Primary Prevention
- (2010) Kausik K. Ray ARCHIVES OF INTERNAL MEDICINE
- By Jove! What Is a Clinician to Make of JUPITER?
- (2010) Sanjay Kaul ARCHIVES OF INTERNAL MEDICINE
- Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy
- (2010) Michel de Lorgeril ARCHIVES OF INTERNAL MEDICINE
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression Analysis
- (2010) Dirk Bassler JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary
- (2010) Philip Greenland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- (2009) John J.V. McMurray et al. CIRCULATION
- From Here to JUPITER
- (2009) Erica S. Spatz et al.
- The JUPITER Trial
- (2009) Paul M Ridker
- Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
- (2009) Paul M Ridker et al.
- Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.
- (2009) Erin D. Michos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid lowering for primary prevention
- (2009) Salim Yusuf et al. LANCET
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Early stopping of randomized clinical trials for overt efficacy is problematic
- (2008) Dirk Bassler et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
- (2008) Edward J. Mills et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis
- (2008) Sripal Bangalore et al. LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started